Hit-to-lead drug development

/Hit-to-lead drug development
Hit-to-lead drug development 2019-01-08T12:54:27+00:00

Recepton’s integrated panel of drug discovery methods includes:

  • NMR fragment based drug discovery
  • High throughput screening (HTS) by HTRF and DSF methods
  • AIDA-NMR
  • Cell-based assays
  • ADME